New hope for advanced cancer: experimental drug 3D185 enters human testing
NCT ID NCT04221204
First seen Mar 29, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This early-stage study tests a new drug called 3D185 in 42 adults with advanced solid tumors who have run out of standard treatments. The main goal is to check the drug's safety and how the body processes it, while also looking for any signs that it might shrink tumors. Participants receive the drug alone, and researchers monitor side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarcoma Oncolog Research Center
Santa Monica, California, 90403, United States
-
Shanghai East Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.